NCT05523609View on ClinicalTrials.gov

Vitamin D and Calcium Supplementation in Breast Cancer

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

September 30, 2024

Study Completion Date

October 31, 2024

Conditions
Breast Cancer
Interventions
DRUG

Letrozole 2.5mg

20 patients will receive Letrozole only for 12 weeks

DRUG

Letrozole + vitamin D3 and calcium

20 patients will receive Letrozole in addition to 2000 IU vitamin D3 per day for 12 weeks.

Trial Locations (1)

GHR

RECRUITING

Tanta Cancer Center, Tanta

All Listed Sponsors
lead

Tanta University

OTHER